Metraipolis › archive › dc_74bf889754ff

Proteoglycan-4 potentiates the antitumor efficacy of regorafenib in an orthotopic model of hepatocellular carcinoma — Europe PMC PMID:41327374

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41327374
DOI: 10.1186/s13046-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-11-08T03:09:33.051Z
SHA-256 of the archived text: 50d28f2d8cb3a4bafabc1c83f8fca047842419c1fdcd4ac78814accbec6735b3
Stable URL of this page: https://metraipolis.com/documento/dc_74bf889754ff

How to cite

Proteoglycan-4 potentiates the antitumor efficacy of regorafenib in an orthotopic model of hepatocellular carcinoma — Europe PMC PMID:41327374 — Europe PMC (en), https://europepmc.org/article/MED/41327374 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_74bf889754ff (Metraipolis archive dc_74bf889754ff, sha256 50d28f2d8cb3a4bafabc1c83f8fca047842419c1fdcd4ac78814accbec6735b3)

BibTeX

@misc{dc74bf889754ff,
  title = {Proteoglycan-4 potentiates the antitumor efficacy of regorafenib in an orthotopic model of hepatocellular carcinoma — Europe PMC PMID:41327374},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41327374},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_74bf889754ff; sha256 50d28f2d8cb3a4bafabc1c83f8fca047842419c1fdcd4ac78814accbec6735b3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41327374. Agents can read the archived copy with the MCP tool read_document.